These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
21. Comparison of trifluoperazine and molindone in chronic schizophrenic patients. Freeman H; Frederick AN Curr Ther Res Clin Exp; 1969 Nov; 11(11):670-6. PubMed ID: 4982301 [No Abstract] [Full Text] [Related]
22. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients. Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W Behav Neuropsychiatry; 1971; 3(5):25-32. PubMed ID: 4948596 [No Abstract] [Full Text] [Related]
23. U-22,394A: a controlled evaluation in chronic schizophrenic patients. Gallant DM; Bishop MP; Bishop G; O'Meallie L Curr Ther Res Clin Exp; 1967 Nov; 9(11):579-81. PubMed ID: 4965508 [No Abstract] [Full Text] [Related]
24. Oxypertine in tardive dyskinesia: an 8-week controlled study. Soni SD; Freeman HL; Hussein EM Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973 [TBL] [Abstract][Full Text] [Related]
25. Oxypertine in schizophrenic psychoses. Controlled clinical trial in two psychiatric hospitals. Vinar O; Hamouz V; Bastecký J Act Nerv Super (Praha); 1968 Oct; 10(3):315-7. PubMed ID: 4883240 [No Abstract] [Full Text] [Related]
26. A multicentre clinical trial of oxypertine in anxiety neurosis. Mungavin JM Postgrad Med J; 1972 Sep; 48(4):Suppl 4:47-54. PubMed ID: 4585548 [No Abstract] [Full Text] [Related]
27. Clothiapin in the treatment of chronic schizophrenia. Malm U Curr Ther Res Clin Exp; 1970 May; 12(5):261-70. PubMed ID: 4986241 [No Abstract] [Full Text] [Related]
28. EEG investigations on the action of Chlordelazine, Oxypertin and Fluanxol in chronic schizophrenia. Predescu V; Roman I Electroencephalogr Clin Neurophysiol; 1969 Dec; 27(6):633-4. PubMed ID: 4188856 [No Abstract] [Full Text] [Related]
29. Molindone: a crossover evaluation of capsule and tablet formulations in severely ill schizophrenic patients. Gallant DM; Bishop MP; Steele CA; Bishop G; Guerrero-Figueroa R Curr Ther Res Clin Exp; 1973 Dec; 15(12):915-8. PubMed ID: 4203575 [No Abstract] [Full Text] [Related]
30. [Clinical studies with oxypertine in chronically psychotic patients]. Eckmann F; Badalik L Arzneimittelforschung; 1970 Feb; 20(2):268-9. PubMed ID: 5467473 [No Abstract] [Full Text] [Related]
31. Clopenthixol in schizophrenia. Comparison of two groups of patients treated by the same drug. Vinar O; Bastecký J; Taussigová D; Formánková M; Růzicka S Act Nerv Super (Praha); 1967 Nov; 9(4):401-4. PubMed ID: 4889074 [No Abstract] [Full Text] [Related]
32. A comparative trial of oxypertine and chlorpromazine in chronic schizophrenia. Neal CD; Collis MP; Imlah NW Curr Ther Res Clin Exp; 1969 Jun; 11(6):367-78. PubMed ID: 4979985 [No Abstract] [Full Text] [Related]
33. [Results of oxypertine therapy of chronic schizophrenia]. Marcjan K; Cwiertnia T; Wolak E Psychiatr Pol; 1970; 4(1):63-7. PubMed ID: 5421204 [No Abstract] [Full Text] [Related]
34. Comparative clinical study of oxyprothepin and clothepin in psychoses. Svejkovská J; Kindernayová H; Zapletálik M Act Nerv Super (Praha); 1978 Dec; 20(4):270. PubMed ID: 32726 [No Abstract] [Full Text] [Related]
35. Is oxypertine an activating tranquillizer? Merskey H; Buhrich N Postgrad Med J; 1972 Sep; 48(4):Suppl 4:26-9. PubMed ID: 4668282 [No Abstract] [Full Text] [Related]
36. [Our experience with oxypertine in chronic schizophrenia]. Pascalis G; Chauvot B Therapie; 1968; 23(4):975-8. PubMed ID: 5744601 [No Abstract] [Full Text] [Related]
37. A double-blind comparison of molindone and trifluoperazine in the treatment of acute schizophrenia. Simpson GM; Amin M; Edwards JG J Clin Pharmacol New Drugs; 1971; 11(3):227-36. PubMed ID: 4946101 [No Abstract] [Full Text] [Related]
38. Clinical evaluation of a new psychotropic drug--molindone. Ramsay RA; Lehmann HE; Ban TA; Saxena BM; Bennett J Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):46-8. PubMed ID: 4909378 [No Abstract] [Full Text] [Related]
39. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings]. Chien C; Jung K; Ross-Townsend A Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102 [No Abstract] [Full Text] [Related]
40. Clinical evaluation of mazindol in chronic schizophrenics. Krumholz WV; White L Curr Ther Res Clin Exp; 1970 Sep; 12(9):609-10. PubMed ID: 4989693 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]